Figure 6 Proposed arrhythmogenic right ventricular

Slides:

Advertisements

Similar presentations

Nat. Rev. Cardiol. doi: /nrcardio

Advertisements

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Factors modulating SCN5A gene expression

Figure 1 Cine cardiovascular magnetic resonance (CMR)

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Two approaches to therapeutic genome editing

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 1 Inducers of the NLRP3 inflammasome related

Figure 2 Size categorization of airborne pollutants

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Systemic Sarcoidosis and Cardiac Conduction Abnormalities

Figure 6 Speckle tracking echocardiography to

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Proposed clinical approach in athletes

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 A patient with aortic and mitral stenosis

Figure 2 The depolarization theory of Brugada syndrome

Figure 1 Decision tree integrating the assessment,

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Global cost of HF per capita in 2012

Figure 2 A patient with aortic stenosis and mitral regurgitation

Figure 5 Examples of biomarker-guided trials

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Milestones in coronary angioplasty

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Effects of cardiovascular medication on the fetus

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Observational studies on multiple treatment strategies

Figure 2 Developmental and alternative sources of fibroblasts

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Enrichment strategies for clinical trials

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Effects of stress

Andrew D. Krahn, MD, Shubhayan Sanatani, MD, Martin J

Nat. Rev. Cardiol. doi: /nrcardio

Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. Diagnosis at presentation and diagnoses finally reached.

Nat. Rev. Cardiol. doi: /nrcardio

Presentation transcript:

Figure 6 Proposed arrhythmogenic right ventricular cardiomyopathy (ARVC)-continuum in relation to exercise dose Figure 6 | Proposed arrhythmogenic right ventricular cardiomyopathy (ARVC)-continuum in relation to exercise dose. Patients with classic, nonexercise-related ARVC and patients with a gene-elusive ARVC (or ARVC-like) cardiomyopathy (CM) in which exercise has a central aetiological role represent the two extremes of this continuum. Variable degrees of exercise and genetic susceptibility would contribute to intermediate forms of the disease. An overview of the most representative studies supporting the role of exercise in the development of ARVC are shown. Negative studies are not shown because they would largely vary depending on the outcome considered (clinical, morphological, and electrophysiological). RV, right ventricular. Guasch, E. & Mont, L. (2016) Diagnosis, pathophysiology, and management of exercise-induced arrhythmias Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.173